{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:54:08Z","timestamp":1791132848871,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,9,11]],"date-time":"2005-09-11T00:00:00Z","timestamp":1126396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1038\/nm1298","type":"journal-article","created":{"date-parts":[[2005,9,11]],"date-time":"2005-09-11T18:04:02Z","timestamp":1126461842000},"page":"1088-1095","source":"Crossref","is-referenced-by-count":330,"title":["17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration"],"prefix":"10.1038","volume":"11","author":[{"given":"Masahiro","family":"Waza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Minamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Doyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,11]]},"reference":[{"key":"BFnm1298_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/153537020322800201","volume":"228","author":"WB Pratt","year":"2003","unstructured":"Pratt, W.B. & Toft, D.O. Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery. Exp. Biol. Med. (Maywood) 228, 111\u2013133 (2003).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"BFnm1298_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1023\/A:1006382320697","volume":"17","author":"L Neckers","year":"1999","unstructured":"Neckers, L., Schulte, T.W. & Mimnaugh, E. Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity. Invest. New Drugs 17, 361\u2013373 (1999).","journal-title":"Invest. New Drugs"},{"key":"BFnm1298_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF00689048","volume":"36","author":"JG Supko","year":"1995","unstructured":"Supko, J.G., Hickman, R.L., Grever, M.R. & Malspeis, L. Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother. Pharmacol. 36, 305\u2013315 (1995).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnm1298_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002800050817","volume":"42","author":"TW Schulte","year":"1998","unstructured":"Schulte, T.W. & Neckers, L.M. The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycin. Cancer Chemother. Pharmacol. 42, 273\u2013279 (1998).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnm1298_CR5","first-page":"308","volume":"38","author":"J Page","year":"1997","unstructured":"Page, J. et al. Comparison of geldanamycin (NSC-122750) and 17-allylaminogeldanamycin (NSC-330507D) toxicity in rats. Proc. Am. Assoc. Cancer Res. 38, 308 (1997).","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"BFnm1298_CR6","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1074\/jbc.272.12.8007","volume":"272","author":"W Sullivan","year":"1997","unstructured":"Sullivan, W. et al. Nucleotides and two functional states of hsp90. J. Biol. Chem. 272, 8007\u20138012 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm1298_CR7","first-page":"2076","volume":"7","author":"R Bagatell","year":"2001","unstructured":"Bagatell, R. et al. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Clin. Cancer Res. 7, 2076\u20132084 (2001).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1298_CR8","first-page":"962","volume":"8","author":"L Neckers","year":"2002","unstructured":"Neckers, L. Heat shock protein 90 inhibition by 17-allylamino-17-demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer. Clin. Cancer Res. 8, 962\u2013966 (2002).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1298_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1379\/1466-1268(2003)008<0108:PASPWC>2.0.CO;2","volume":"8","author":"SJ Felts","year":"2003","unstructured":"Felts, S.J. & Toft, D.O. p23, a simple protein with complex activities. Cell Stress Chaperones 8, 108\u2013113 (2003).","journal-title":"Cell Stress Chaperones"},{"key":"BFnm1298_CR10","first-page":"670","volume":"9","author":"JL Johnson","year":"1995","unstructured":"Johnson, J.L. & Toft, D.O. Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol. Endocrinol. 9, 670\u2013678 (1995).","journal-title":"Mol. Endocrinol."},{"key":"BFnm1298_CR11","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1128\/MCB.15.12.6804","volume":"15","author":"DF Smith","year":"1995","unstructured":"Smith, D.F. et al. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol. Cell. Biol. 15, 6804\u20136812 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm1298_CR12","first-page":"705","volume":"10","author":"L Whitesell","year":"1996","unstructured":"Whitesell, L. & Cook, P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol. 10, 705\u2013712 (1996).","journal-title":"Mol. Endocrinol."},{"key":"BFnm1298_CR13","doi-asserted-by":"publisher","first-page":"14536","DOI":"10.1073\/pnas.93.25.14536","volume":"93","author":"C Schneider","year":"1996","unstructured":"Schneider, C. et al. Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc. Natl. Acad. Sci. USA 93, 14536\u201314541 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1298_CR14","first-page":"986","volume":"8","author":"DB Solit","year":"2002","unstructured":"Solit, D.B. et al. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2\/neu and inhibits the growth of prostate cancer xenografts. Clin. Cancer Res. 8, 986\u2013993 (2002).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1298_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1379\/1466-1268(2002)007<0055:EOGOAR>2.0.CO;2","volume":"7","author":"DK Vanaja","year":"2002","unstructured":"Vanaja, D.K., Mitchell, S.H., Toft, D.O. & Young, C.Y. Effect of geldanamycin on androgen receptor function and stability. Cell Stress Chaperones 7, 55\u201364 (2002).","journal-title":"Cell Stress Chaperones"},{"key":"BFnm1298_CR16","first-page":"4961","volume":"9","author":"J Beliakoff","year":"2003","unstructured":"Beliakoff, J. et al. Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors. Clin. Cancer Res. 9, 4961\u20134971 (2003).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1298_CR17","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1158\/0008-5472.CAN-03-3531","volume":"64","author":"P Bonvini","year":"2004","unstructured":"Bonvini, P., Dalla Rosa, H., Vignes, N. & Rosolen, A. Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein. Cancer Res. 64, 3256\u20133264 (2004).","journal-title":"Cancer Res."},{"key":"BFnm1298_CR18","doi-asserted-by":"publisher","first-page":"22796","DOI":"10.1074\/jbc.271.37.22796","volume":"271","author":"EG Mimnaugh","year":"1996","unstructured":"Mimnaugh, E.G., Chavany, C. & Neckers, L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J. Biol. Chem. 271, 22796\u201322801 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm1298_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature01913","volume":"425","author":"A Kamal","year":"2003","unstructured":"Kamal, A. et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425, 407\u2013410 (2003).","journal-title":"Nature"},{"key":"BFnm1298_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2174\/1568009033481787","volume":"3","author":"L Whitesell","year":"2003","unstructured":"Whitesell, L., Bagatell, R. & Falsey, R. The stress response: implications for the clinical development of hsp90 inhibitors. Curr. Cancer Drug Targets 3, 349\u2013358 (2003).","journal-title":"Curr. Cancer Drug Targets"},{"key":"BFnm1298_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrn1587","volume":"6","author":"PJ Muchowski","year":"2005","unstructured":"Muchowski, P.J. & Wacker, J.L. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6, 11\u201322 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnm1298_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","volume":"10","author":"A Sittler","year":"2001","unstructured":"Sittler, A. et al. Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum. Mol. Genet. 10, 1307\u20131315 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/hmg\/ddh144","volume":"13","author":"DG Hay","year":"2004","unstructured":"Hay, D.G. et al. Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet. 13, 1389\u20131405 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nm1102-1185","volume":"8","author":"PK Auluck","year":"2002","unstructured":"Auluck, P.K. & Bonini, N.M. Pharmacological prevention of Parkinson disease in Drosophila . Nat. Med. 8, 1185\u20131186 (2002).","journal-title":"Nat. Med."},{"key":"BFnm1298_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.242720499","volume":"100","author":"F Dou","year":"2003","unstructured":"Dou, F. et al. Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. USA 100, 721\u2013726 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1298_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703\u2013714 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1046\/j.1471-4159.2002.00835.x","volume":"81","author":"A Lu","year":"2002","unstructured":"Lu, A., Ran, R., Parmentier-Batteur, S., Nee, A. & Sharp, F.R. Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J. Neurochem. 81, 355\u2013364 (2002).","journal-title":"J. Neurochem."},{"key":"BFnm1298_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jnr.10139","volume":"67","author":"P Murphy","year":"2002","unstructured":"Murphy, P. et al. Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis. J. Neurosci. Res. 67, 461\u2013470 (2002).","journal-title":"J. Neurosci. Res."},{"key":"BFnm1298_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77\u201379 (1991).","journal-title":"Nature"},{"key":"BFnm1298_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue, G. et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 112, 209\u2013232 (1989).","journal-title":"Brain"},{"key":"BFnm1298_CR31","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"HY Zoghbi","year":"2000","unstructured":"Zoghbi, H.Y. & Orr, H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217\u2013247 (2000).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFnm1298_CR32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/hmg\/5.9.1253","volume":"5","author":"F Tanaka","year":"1996","unstructured":"Tanaka, F. et al. Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum. Mol. Genet. 5, 1253\u20131257 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ana.410320517","volume":"32","author":"M Doyu","year":"1992","unstructured":"Doyu, M. et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol. 32, 707\u2013710 (1992).","journal-title":"Ann. Neurol."},{"key":"BFnm1298_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H Adachi","year":"2005","unstructured":"Adachi, H. et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128, 659\u2013670 (2005).","journal-title":"Brain"},{"key":"BFnm1298_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","volume":"35","author":"M Katsuno","year":"2002","unstructured":"Katsuno, M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843\u2013854 (2002).","journal-title":"Neuron"},{"key":"BFnm1298_CR36","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","volume":"23","author":"H Adachi","year":"2003","unstructured":"Adachi, H. et al. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci. 23, 2203\u20132211 (2003).","journal-title":"J. Neurosci."},{"key":"BFnm1298_CR37","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nm878","volume":"9","author":"M Katsuno","year":"2003","unstructured":"Katsuno, M. et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med. 9, 768\u2013773 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1298_CR38","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","volume":"13","author":"M Minamiyama","year":"2004","unstructured":"Minamiyama, M. et al. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13, 1183\u20131192 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/hmg\/11.5.515","volume":"11","author":"CK Bailey","year":"2002","unstructured":"Bailey, C.K., Andriola, I.F., Kampinga, H.H. & Merry, D.E. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 11, 515\u2013523 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR40","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","volume":"11","author":"AP Lieberman","year":"2002","unstructured":"Lieberman, A.P., Harmison, G., Strand, A.D., Olson, J.M. & Fischbeck, K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 11, 1967\u20131976 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm1298_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0092-8674(00)81588-3","volume":"94","author":"J Zou","year":"1998","unstructured":"Zou, J., Guo, Y., Guettouche, T., Smith, D.F. & Voellmy, R. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94, 471\u2013480 (1998).","journal-title":"Cell"},{"key":"BFnm1298_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s002800000242","volume":"47","author":"MJ Egorin","year":"2001","unstructured":"Egorin, M.J. et al. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother. Pharmacol. 47, 291\u2013302 (2001).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnm1298_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"BFnm1298_CR44","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","volume":"24","author":"RJ Ferrante","year":"2004","unstructured":"Ferrante, R.J. et al. Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease. J. Neurosci. 24, 10335\u201310342 (2004).","journal-title":"J. Neurosci."},{"key":"BFnm1298_CR45","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/502","volume":"19","author":"CJ Cummings","year":"1998","unstructured":"Cummings, C.J. et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19, 148\u2013154 (1998).","journal-title":"Nat. Genet."},{"key":"BFnm1298_CR46","doi-asserted-by":"publisher","first-page":"8772","DOI":"10.1074\/jbc.275.12.8772","volume":"275","author":"Y Kobayashi","year":"2000","unstructured":"Kobayashi, Y. et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J. Biol. Chem. 275, 8772\u20138778 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm1298_CR47","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1073\/pnas.93.16.8379","volume":"93","author":"MV Blagosklonny","year":"1996","unstructured":"Blagosklonny, M.V., Toretsky, J., Bohen, S. & Neckers, L. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA 93, 8379\u20138383 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1298_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J.J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"BFnm1298_CR49","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia, H. et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10, 816\u2013820 (2004).","journal-title":"Nat. Med."},{"key":"BFnm1298_CR50","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1471-4159.2002.00998.x","volume":"82","author":"S Ishigaki","year":"2002","unstructured":"Ishigaki, S. et al. X-Linked inhibitor of apoptosis protein is involved in mutant SOD1-mediated neuronal degeneration. J. Neurochem. 82, 576\u2013584 (2002).","journal-title":"J. Neurochem."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1298","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:24:18Z","timestamp":1684448658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,11]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["BFnm1298"],"URL":"https:\/\/doi.org\/10.1038\/nm1298","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,11]]}}}